In a filing, Hims & Hers Health Inc revealed its Officer Chi Michael acquired Company’s shares for reported $0.17 million on Jan 10 ’25. In the deal valued at $24.07 per share,7,259 shares were bought.
Then, Boughton Soleil sold 268,932 shares, generating $7,463,195 in total proceeds. Upon selling the shares at $27.75, the Chief Legal Officer now owns 169,803 shares.
Before that, Okupe Oluyemi sold 11,581 shares. Hims & Hers Health Inc shares valued at $285,784 were divested by the Chief Financial Officer at a price of $24.68 per share. As a result of the transaction, Okupe Oluyemi now holds 123,221 shares, worth roughly $3.19 million.
Citigroup downgraded its Hims & Hers Health Inc [HIMS] rating to a Sell from a a Neutral in a research note published on January 10, 2025; the price target was increased to $25 from $24. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. Morgan Stanley began covering HIMS with “an Overweight” recommendation on December 17, 2024. BofA Securities revised its rating on November 14, 2024. It rated HIMS as “an Underperform” which previously was an “a Buy”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 1.93% to $25.90. Over the last five days, the stock has lost -2.74%. Hims & Hers Health Inc shares have risen nearly 7.11% since the year began. Nevertheless, the stocks have risen 200.12% over the past one year. While a 52-week high of $35.02 was reached on 01/07/25, a 52-week low of $8.14 was recorded on 01/10/25. SMA at 50 days reached $26.73, while 200 days put it at $19.97.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 24.61, which if violated will result in even more drops to 23.33. On the upside, there is a resistance level at 26.78. A further resistance level may holdings at 27.67. The Relative Strength Index (RSI) on the 14-day chart is 46.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.73, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.29%. Stochastics %K at 24.34% indicates the stock is a holding.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2024-12-31, growing by 9.5 million shares to a total of 52.12 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 42.62 million shares. There was a rise of 18.23%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 22, 2024 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $24 price target.
